Bottom line
PAWZ vs AIVSX: the short answer
PAWZ (ProShares Pet Care ETF) and AIVSX (Investment Co Of America) are both etfs.
But AIVSX is far broader, holding 161 positions to 38 for PAWZ, so beyond the top names it adds exposure PAWZ doesn't have.
PAWZ is cheaper at 0.5% vs 0.55% — a difference of $5.00 a year per $10,000 invested.
Over five years, AIVSX returned +14.0% a year vs −4.7% for PAWZ.
AIVSX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
PAWZ vs AIVSX side by side
| PAWZ | AIVSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ProShares | American Funds (Capital Group) |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.5% | 0.55% |
| Annual cost per $10k | $50 | $55 |
| 10-yr cost on $10k (prospectus) | $628 | $1,225 |
| Max front load | None | 5.75% |
| 12b-1 fee | — | 0.24% |
| 1-yr return | +0.9% | +13.6% |
| 5-yr return (annualized) | −4.7% | +14.0% |
| 10-yr return (annualized) | — | +13.4% |
| Best quarter | +26.2% | +19.2% |
| Worst quarter | −20.7% | −19.0% |
| Net assets (fund) | $32.5M | $184.2B |
| Number of holdings | 38 | 161 |
| Portfolio turnover | 41% | 34% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
PAWZ and AIVSX share none of their top holdings.
PAWZ top 10
- IDEXX Laboratories, Inc. — 10.15%
- Chewy, Inc. — 9.90%
- Freshpet, Inc. — 9.81%
- Zoetis, Inc. — 9.46%
- Virbac SACA — 7.37%
- CVS Group plc — 4.99%
- Merck & Co., Inc. — 4.84%
- Pets at Home Group plc — 4.71%
- Nestle SA — 4.64%
- Oil-Dri Corp. of America — 4.50%
AIVSX top 10
- Nvidia Corp — 6.81%
- Broadcom Inc — 6.49%
- Microsoft Corp — 5.13%
- Amazon.com Inc — 5.00%
- Meta Platforms Inc — 3.61%
- Eli Lilly And Co — 2.94%
- Alphabet Inc — 2.87%
- British American Tobacco Plc — 2.43%
- Alphabet Inc — 2.40%
- Philip Morris International Inc — 2.31%
FAQ
What is the difference between PAWZ and AIVSX?
Which is cheaper, PAWZ or AIVSX?
Should I own both PAWZ and AIVSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.